Xuefei Guo

This paper shows Betrixaban activates cGAS and ERVs to trigger antiviral immunity through dual pathways, suggesting its repurposing as a broad-spectrum antiviral.

This study shows PARP14 inhibits macrophage inflammatory responses by suppressing the NF-κB pathway, as demonstrated through genetic knockout and pharmacological inhibition.

CBRPP identifies RNA-associated proteins in native cells without cross-linking or RNA manipulation.